Chalmers, J. D., Burgel, P., Daley, C. L., De Soyza, A., Haworth, C. S., Mauger, D., . . . Metersky, M. L. (2025). Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. The New England journal of medicine, 392(16), 1569-1581. https://doi.org/10.1056/NEJMoa2411664
Citace podle Chicago (17th ed.)Chalmers, James D., et al. "Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis." The New England Journal of Medicine 392, no. 16 (2025): 1569-1581. https://doi.org/10.1056/NEJMoa2411664.
Citace podle MLA (9th ed.)Chalmers, James D., et al. "Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis." The New England Journal of Medicine, vol. 392, no. 16, 2025, pp. 1569-1581, https://doi.org/10.1056/NEJMoa2411664.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..